SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as investors react to news of Elon Musk's $1 billion purchase of TSLA shares, his first buy since 2020, which the community sees as a strong confidence signal.  Discussions revolve around potential short squeezes and the impact on the stock's valuation, with some questioning fundamentals while others anticipate further gains.  The move occurs amid ongoing conversations about Tesla's role in the EV market and Musk's broader ventures.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is trending due to speculation surrounding a potential SOL treasury announcement and recent positive outcomes from their stroke study, leading to discussions about a possible short squeeze. Community members are actively debating the stock's potential for a significant run, drawing comparisons to other companies that have launched crypto treasury initiatives. However, concerns remain regarding the company's history of reverse splits and dilution.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as the community discusses potential catalysts like FAA certification and new partnerships, while also debating whether recent price action indicates a buying opportunity or further downside. Some speculate about government contracts and compare ACHR to competitors like $JOBY in the eVTOL space. Concerns about a short report and the CEO's communication are also prevalent.

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

NanoVibronix Inc

NanoVibronix is trending as traders discuss its low float and potential short squeeze, following news of a granted U.S. patent for pediatric feeding tube guidance. Community members are actively monitoring price levels and volume, with some anticipating a significant upward move, while others remain cautious due to the stock's history of reverse splits. Discussions also involve potential price targets and the impact of the new patent on the company's commercialization path.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Asset Entities Inc.

Asset Entities Inc. ($ASST) is trending due to high volatility following its merger, with discussions focused on trading halts and the potential for a short squeeze. The community is debating the impact of a new share repurchase program and potential Bitcoin purchases, while also noting the CUSIP change affecting trading on some platforms. Overall, traders are closely watching the stock's price action and the potential for significant swings.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is trending amidst discussions around its high short interest, potential for a short squeeze, and the upcoming launch of its Rumble Wallet. Some see the stock as a play on a shift in media and cloud services towards platforms valuing free speech, further fueled by the perceived support from prominent figures. Additionally, the possible acquisition of Northern Data and its impact on Rumble's cloud capacity is a hot topic.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amid news of significant institutional investment and accumulation, particularly by Galaxy Digital. The community is also focused on the potential of Solana-based meme coins, alongside existing projects, and discussing potential breakout zones with some eyeing a move towards higher price targets. Also, the $WAGMI.X community is actively supporting Solana.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics is trending following a licensing deal with Novartis to develop molecular glue degraders for immune-mediated diseases, potentially worth billions. The community is speculating about a possible bidding war for the company between Novartis and Roche. Discussions also revolve around the company's cash position and potential price target upgrades.

PennyMac Financial Services, Inc. is a holding company, which engages in the production and servicing of U.S. residential mortgage loans. It operates through the following segments: Loan Production, Loan Servicing, and Investment Management. The Loan Production segment is sourced through three channels: correspondent production, consumer direct lending, and broker direct lending. The Loan Servicing segment performs loan administration, collection, and default management activities. The Investment Management segment currently manages PennyMac Mortgage Investment Trust. The company was founded by Stanford L. Kurland on July 2, 2008 and is headquartered in Westlake Village, CA.

PennyMac Financial Services Inc.

PFSI is trending as investors discuss the mortgage industry and potential impacts from rising rates. Community members are weighing the company's financial health and future prospects in a changing economic environment. Discussions include analyst ratings and price target adjustments.

Grab Holdings Ltd. engages in the provision of millions of people each day to access its driver- and merchant-partners to order food or groceries, send packages, hail a ride or taxi, pay for online purchases or access services such as lending, insurance, wealth management and telemedicine, all through a single “everyday everything” app. The firm operates in food deliveries and mobility and by TPV in the e-wallets segment of financial services in Southeast Asia. It operates across the deliveries, mobility and digital financial services sectors in eight countries namely: Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam. The company was founded by Anthony Tan Ping Yeow and Tan Hooi Ling in 2012 and is headquartered in Singapore.

Grab Holdings Limited - Ordinary Shares - Class A

Grab Holdings Limited

Grab Holdings is trending as investors discuss its recent profit turnaround and potential for significant growth, fueled by its dominance in Southeast Asia's super-app market. Community members are highlighting the company's improving financials, technical breakouts, and potential mergers, contributing to bullish sentiment. Some are comparing it to other high-growth tech companies, suggesting considerable long-term upside.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?

TEM's Q2 net loss narrows sharply, driven by surging genomics revenues, higher gross profits and tighter cost controls.

TMO Receives FDA Approval for Oncomine Dx Target Test

Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.

TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?

Tempus AI raises 2025 revenue outlook again after strong Q2 growth in genomics and AI-driven oncology solutions.

Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of +15.38% and +9.77%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Tempus AI Taps Growing ICI Market With New xM Assay

TEM launches xM, a liquid biopsy assay to monitor real-time response to ICI therapy in advanced solid tumors.

Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release

TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?  

Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?

Cathie Wood's Ark&nbsp;Investment Management has increased its stake in Amazon.com (AMZN)&nbsp;by purchasing another $6.2 million worth of shares, according to its disclosure on Tuesday.ARK Next Generation Internet ETF (ARKW) added 29,837 shares of the e-commerce and cloud company.ARK is one of the most closely watched funds in the market, and its trades typically have a bearing on investor sentiment.The fund also bought $6.1 million worth of shares of Advanced Micro Devices (AMD) and $7.3 million worth of shares of Guardant Health (GH).It sold $13 million worth of shares of CoreWeave (CRWV) and about $6 million of Palantir Technologies (PLTR) after a recent&nbsp;rally in&nbsp;both stocks.CoreWeave has climbed 276% since its initial public offering in March, and Palantir currently trades at an all-time high, having been the one of the best-performing stocks with a 76% year-to-date gain.ARK bought $9.3 million worth of Amazon shares in April when the stock was battered by the news of tariffs.The increased exposure signals that investors are confident of Amazon's ability to navigate the macroeconomic headwinds while maintaining its growth.Earlier this week, Bank of America raised its price target on Amazon stock to $248 from $230 while maintaining its 'Buy' rating.On Stocktwits, however, retail sentiment for Amazon was 'bearish,' unchanged from the previous week.<figure class="image"><img style="aspect-ratio:568/69;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_04_at_7_58_30_AM_png_bc6e00d1ea.webp" alt="Screenshot 2025-06-04 at 7.58.30 AM.png" width="568" height="69"><figcaption>AMZN sentiment and message volume as of June 3 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/AMZN">AMZN shares</a> are down 6.2% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cathie Wood, Founder & CEO, Ark Invest, speaks during the second day of the FII PRIORITY Summit

Cathie Wood's ARK Invest Buys More Amazon Stock: Retail Still On The Sidelines

The widely watched investor also bought AMD and Guardant Health stocks, while cutting its stakes in CoreWeave and Palantir.

Equity

The widely watched investor also bought AMD and Guardant Health stocks, while cutting its stakes in CoreWeave and Palantir.


Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Current Price	$54.70
Prev Close	$54.90
Open	$54.52
Dividend Yield	0.00%
50-Day Moving Average	$53.47
Beta	1.54
Avg. Volume	2.82M
PE Ratio	-16.41

52-Week High	$68.00
52-Week Low	$20.14
Market Capitalization	$6.85B
EPS (Annual)	-$3.56
Price to Book	-22.37
Revenue Per Employee	$365,668.48
Enterprise Value/EBITDA	N/A

GH
Guardant Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GH News

GH Guardant Health Inc